Literature DB >> 19280114

Decreased anxiety in mice lacking the organic cation transporter 3.

Thomas Wultsch1, Gundula Grimberg, Angelika Schmitt, Evelin Painsipp, Heike Wetzstein, Alexandra Frauke Stephanie Breitenkamp, Dirk Gründemann, Edgar Schömig, Klaus-Peter Lesch, Manfred Gerlach, Andreas Reif.   

Abstract

The organic cation transporter 3 (OCT3; synonymous: extraneuronal monoamine transporter, EMT, Slc22a3) encodes an isoform of the organic cation transporters and is expressed widely across the whole brain. OCTs are a family of high-capacity, bidirectional, multispecific transporters of organic cations. These also include serotonin, dopamine and norepinephrine making OCTs attractive candidates for a variety of neuropsychiatric disorders including anxiety disorders. OCT3 has been implicated in termination of monoaminergic signalling in the central nervous system. Interestingly, OCT3 mRNA is however also significantly up-regulated in the hippocampus of serotonin transporter knockout mice where it might serve as an alternative reuptake mechanism for serotonin. The examination of the behavioural phenotype of OCT3 knockout mice thus is paramount to assess the role of OCT3. We have therefore subjected mice lacking the OCT3 gene to a comprehensive behavioural test battery. While cognitive functioning in the Morris water maze test and aggression levels measured with the resident-intruder paradigm were in the same range as the respective control animals, OCT3 knockout animals showed a tendency of increased activity and were significantly less anxious in the elevated plus-maze test and the open field test as compared to their respective wild-type controls arguing for a role of OCT3 in the regulation of fear and anxiety, probably by modulating the serotonergic tone in limbic circuitries.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19280114     DOI: 10.1007/s00702-009-0205-1

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  59 in total

1.  THE UPTAKE OF ADRENALINE BY THE RAT ISOLATED HEART.

Authors:  L L IVERSEN
Journal:  Br J Pharmacol Chemother       Date:  1965-04

2.  Locomotory patterns, spatiotemporal organization of exploration and spatial memory in serotonin transporter knockout mice.

Authors:  Allan V Kalueff; Catherine L Jensen; Dennis L Murphy
Journal:  Brain Res       Date:  2007-07-14       Impact factor: 3.252

3.  The role of extraneuronal amine transport systems for the removal of extracellular catecholamines in the rabbit.

Authors:  B Friedgen; R Wölfel; H Russ; E Schömig; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

4.  Common variations in the pretest environment influence genotypic comparisons in models of anxiety.

Authors:  G S Izídio; D M Lopes; L Spricigo; A Ramos
Journal:  Genes Brain Behav       Date:  2005-10       Impact factor: 3.449

Review 5.  [Drug treatment of anxiety disorders].

Authors:  H Scholz; R Lhotka
Journal:  Wien Med Wochenschr       Date:  1991

Review 6.  Applications of the Morris water maze in the study of learning and memory.

Authors:  R D'Hooge; P P De Deyn
Journal:  Brain Res Brain Res Rev       Date:  2001-08

Review 7.  Serotonin-norepinephrine reuptake inhibitors in the treatment of obsessive-compulsive disorder: A critical review.

Authors:  Bernardo Dell'Osso; Gerald Nestadt; Andrea Allen; Eric Hollander
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

8.  Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine.

Authors:  A E Busch; U Karbach; D Miska; V Gorboulev; A Akhoundova; C Volk; P Arndt; J C Ulzheimer; M S Sonders; C Baumann; S Waldegger; F Lang; H Koepsell
Journal:  Mol Pharmacol       Date:  1998-08       Impact factor: 4.436

9.  Transport of monoamine transmitters by the organic cation transporter type 2, OCT2.

Authors:  D Gründemann; S Köster; N Kiefer; T Breidert; M Engelhardt; F Spitzenberger; N Obermüller; E Schömig
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

10.  Aqueous and hydroalcoholic extracts of Black Maca (Lepidium meyenii) improve scopolamine-induced memory impairment in mice.

Authors:  Julio Rubio; Haixia Dang; Mengjuan Gong; Xinmin Liu; Shi-Lin Chen; Gustavo F Gonzales
Journal:  Food Chem Toxicol       Date:  2007-04-20       Impact factor: 6.023

View more
  21 in total

1.  Decynium-22 enhances SSRI-induced antidepressant-like effects in mice: uncovering novel targets to treat depression.

Authors:  Rebecca E Horton; Deana M Apple; W Anthony Owens; Nicole L Baganz; Sonia Cano; Nathan C Mitchell; Melissa Vitela; Georgianna G Gould; Wouter Koek; Lynette C Daws
Journal:  J Neurosci       Date:  2013-06-19       Impact factor: 6.167

2.  Antidepressant efficacy of a selective organic cation transporter blocker in a mouse model of depression.

Authors:  Alejandro Orrico-Sanchez; Laetitia Chausset-Boissarie; Rodolphe Alves de Sousa; Basile Coutens; Sara Rezai Amin; Vincent Vialou; Franck Louis; Assia Hessani; Patrick M Dansette; Teodoro Zornoza; Carole Gruszczynski; Bruno Giros; Bruno P Guiard; Francine Acher; Nicolas Pietrancosta; Sophie Gautron
Journal:  Mol Psychiatry       Date:  2019-10-16       Impact factor: 15.992

Review 3.  The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.

Authors:  Sanjay K Nigam
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-01-06       Impact factor: 13.820

4.  Constitutive plasma membrane monoamine transporter (PMAT, Slc29a4) deficiency subtly affects anxiety-like and coping behaviours.

Authors:  T Lee Gilman; Christina M George; Melissa Vitela; Myrna Herrera-Rosales; Mohamed S Basiouny; Wouter Koek; Lynette C Daws
Journal:  Eur J Neurosci       Date:  2018-05-24       Impact factor: 3.386

5.  Inhibitory potencies of trimipramine and its main metabolites at human monoamine and organic cation transporters.

Authors:  Britta Haenisch; Christoph Hiemke; Heinz Bönisch
Journal:  Psychopharmacology (Berl)       Date:  2011-04-12       Impact factor: 4.530

6.  Prenatal metformin exposure or organic cation transporter 3 knock-out curbs social interaction preference in male mice.

Authors:  Valentina R Garbarino; Taylor A Santos; Anastassia R Nelson; Wynne Q Zhang; Corey M Smolik; Martin A Javors; Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Res       Date:  2018-11-10       Impact factor: 7.658

7.  Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin.

Authors:  Eugene C Chen; Xiaomin Liang; Sook Wah Yee; Ethan G Geier; Sophie L Stocker; Ligong Chen; Kathleen M Giacomini
Journal:  Mol Pharmacol       Date:  2015-04-28       Impact factor: 4.436

8.  Influence of chronic amphetamine treatment and acute withdrawal on serotonin synthesis and clearance mechanisms in the rat ventral hippocampus.

Authors:  Jeffrey L Barr; Jamie L Scholl; Rajeshwari R Solanki; Michael J Watt; Christopher A Lowry; Kenneth J Renner; Gina L Forster
Journal:  Eur J Neurosci       Date:  2012-11-14       Impact factor: 3.386

9.  Revisiting serotonin reuptake inhibitors and the therapeutic potential of "uptake-2" in psychiatric disorders.

Authors:  Lynette C Daws; Wouter Koek; Nathan C Mitchell
Journal:  ACS Chem Neurosci       Date:  2013-01-16       Impact factor: 4.418

10.  Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice.

Authors:  Paul J Gasser; Matthew M Hurley; June Chan; Virginia M Pickel
Journal:  Brain Struct Funct       Date:  2016-09-22       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.